PARP inhibitors (PARPi) are being used in patients with BRCA1/2 mutations; however, doubly deficient BRCA1−/−53BP1−/− tumors become resistant to PARPis. 53BP1 and its known downstream effectors, PTIP and RIF1, lack enzymatic activities directly implicated in DNA repair. Wang et al. uncovered a nuclease, Artemis, as a PTIP-binding protein that trims DNA ends, promotes NHEJ, and directly competes with the HR repair pathway. Loss of Artemis restores PARPi resistance in BRCA1-deficient cells.
PTIP associates with Artemis to dictate DNA repair pathway choice
Jiadong Wang,Asaithamby Aroumougame,M. Lobrich,Yujing Li,David J. Chen,Junjie Chen,Zihua Gong
Published 2014 in Genes & Development
ABSTRACT
PUBLICATION RECORD
- Publication year
2014
- Venue
Genes & Development
- Publication date
2014-12-15
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-34 of 34 references · Page 1 of 1